Get startedLog in
    Picture of Applied BioCode logo

    6598 — Applied BioCode Income Statement

    0.000.00%
    tw flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Applied BioCode, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue299320390395343
    Cost of Revenue
    Gross Profit194189234269204
    Selling / General / Administrative Expenses
    Research And Development
    Total Operating Expenses433485583582621
    Operating Profit-134-165-193-187-278
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-103-165-185-163-261
    Provision for Income Taxes
    Net Income After Taxes-103-165-185-164-261
    Net Income Before Extraordinary Items
    Net Income-103-165-185-164-261
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Dilution Adjustment
    Diluted Net Income-103-165-185-164-261
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-1.25-1.89-2.11-1.87-2.88
    Dividends per Share